MedTrace Logo

Venous Thrombosis Virtual Surveillance in COVID-19

NCT04865913 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 510

Last updated 2023-03-24

No results posted yet for this study

Summary

The overall goal of the VVIRTUOSO study is to determine the incidence of VTE including symptomatic DVT and PE after hospital discharge in patients with COVID-19 by implementing a pragmatic patient-centred prospective virtual VTE monitoring program in Canada and the United States.

Conditions

Interventions

OTHER

Observational

A brief 15 min phone call 1 week, 30 and 90 days post discharge.

Sponsors & Collaborators

  • Canadian Institutes of Health Research (CIHR)

    collaborator OTHER_GOV

  • Ottawa Hospital Research Institute

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-01-13
Primary Completion
2022-12-31
Completion
2022-12-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04865913 on ClinicalTrials.gov